Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Polycythemia Vera × Rituximab × Clear all

Sponsor

Conditions

Lymphoma 150 Leukemia, Lymphocytic, Chronic, B-Cell 138 Lymphoma, Non-Hodgkin 135 Lymphoma, Follicular 117 Lymphoma, Large B-Cell, Diffuse 114 Lymphoma, Mantle-Cell 81 Leukemia 63 Lymphoma, B-Cell, Marginal Zone 59 Waldenstrom Macroglobulinemia 44 Burkitt Lymphoma 37 Lymphoma, B-Cell 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Hodgkin Disease 32 Recurrence 22 Lymphoma, Large-Cell, Immunoblastic 22 Neoplasms 15 Myelodysplastic Syndromes 15 Lymphoma, Large-Cell, Anaplastic 13 Multiple Myeloma 12 Leukemia, Myeloid, Acute 12 Hematologic Neoplasms 9 Lymphoma, T-Cell, Cutaneous 7 Lymphoma, Extranodal NK-T-Cell 7 Leukemia, Prolymphocytic 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Hairy Cell 7 Intraocular Lymphoma 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Myeloproliferative Disorders 6 Leukemia, Myelomonocytic, Chronic 6

Interventions

fludarabine phosphate 16 Whole-Body Irradiation 10 Peripheral Blood Stem Cell Transplantation 9 Mycophenolic Acid 9 ruxolitinib 8 Busulfan 8 Cyclophosphamide 7 Tacrolimus 6 fludarabine 5 Melphalan 5 Cyclosporine 5 Methotrexate 4 Antilymphocyte Serum 4 givinostat hydrochloride 3 givinostat 3 Lenalidomide 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 thymoglobulin 2 pomalidomide 2 Surveys and Questionnaires 2 Stem Cell Transplantation 2 Prednisone 2 Hydroxyurea 2 Etoposide 2 Dasatinib 2 Carboplatin 2 veliparib 1 sonidegib 1 pembrolizumab 1 peginterferon alfa-2a 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡